Within-visit blood pressure variability and cardiovascular risk factors in hypertensive patients with non-dialysis chronic kidney disease.
Kengo AzushimaHiromichi WakuiKazushi UnedaSona HakuRyu KobayashiKohji OhkiSho KinguchiKotaro HaruharaTetsuya FujikawaYoshiyuki ToyaSatoshi UmemuraKouichi TamuraPublished in: Clinical and experimental hypertension (New York, N.Y. : 1993) (2017)
We show that within-visit BP variability may be a clinically relevant factor of CVD risk, and lipid lowering and/or anti-hypertensive therapies using RAS inhibitors and α1-blockers may be associated with the improved within-visit BP variability observed in non-dialysis CKD patients.